<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="92">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    https://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 08, 2015</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01696513</url>
  </required_header>
  <id_info>
    <org_study_id>STU66710</org_study_id>
    <nct_id>NCT01696513</nct_id>
  </id_info>
  <brief_title>Effect of Subcision and Suction on Acne Scars</brief_title>
  <official_title>Pilot Split Face Randomized, Evaluator Blinded Study on the Effect of Subcision and Suctioning With a Microdermabrasion Device on Rolling Acne Scars</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Northwestern University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Northwestern University</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary objective of this study is to determine whether the use of standard treatment in
      conjunction with suction will improve acne scars compared to a standard treatment alone.
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>September 2012</start_date>
  <completion_date type="Anticipated">September 2015</completion_date>
  <primary_completion_date type="Anticipated">September 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Change in acne scarring compared to baseline after treatments</measure>
    <time_frame>Baseline and 4 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>The change in acne scarring is measured using a global scarring grading system to compare baseline scarring to the treatments.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Acne Scars</condition>
  <arm_group>
    <arm_group_label>Subcision &amp; Suction</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Standard treatment for acne scars followed by suction.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Subcision</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Standard treatment for acne scars only</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Suction</intervention_name>
    <arm_group_label>Subcision &amp; Suction</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Subcision</intervention_name>
    <arm_group_label>Subcision &amp; Suction</arm_group_label>
    <arm_group_label>Subcision</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age 18 and over

          -  Have bilateral rolling acne scars

          -  Are in good health

          -  Subject has the willingness and ability to understand and provide informed consent
             for the use of their tissue and communicate with the investigator.

        Exclusion Criteria:

          -  Under 18 years of age

          -  Pregnancy or lactation

          -  Unable to understand the protocol or give informed consent

          -  Has mental illness

          -  Recent Accutane use in the past 6 months

          -  Prone to hypertrophic and keloidal scarring
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Murad Alam, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Northwestern University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Northwestern University Feinberg School of Medicine, Department of Dermatology</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60611</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2015</verification_date>
  <lastchanged_date>March 5, 2015</lastchanged_date>
  <firstreceived_date>September 14, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Northwestern University</investigator_affiliation>
    <investigator_full_name>Murad Alam</investigator_full_name>
    <investigator_title>Professor in Dermatology, Otolaryngology- Head and Neck Surgery, and Surgery-Organ Transplantation</investigator_title>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
